Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer
about
Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat CancerThe core planar cell polarity gene, Vangl2, directs adult corneal epithelial cell alignment and migration.Patterned cortical tension mediated by N-cadherin controls cell geometric order in the Drosophila eye.p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.Planar cell polarity (PCP) proteins and spermatogenesis.Interaction of Epstein-Barr virus genes with human gastric carcinoma transcriptome.p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage.When mTORC2-AKT signaling meets cell polarityRor2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression.The core planar cell polarity gene, Vangl2, maintains apical-basal organisation of the corneal epithelium.Cellular and molecular mechanisms underlying planar cell polarity pathway contributions to cancer malignancy.p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis.Altered tooth morphogenesis after silencing the planar cell polarity core component, Vangl2.Wnt Signalling in Gastrointestinal Epithelial Stem Cells.Identification of common differentially-expressed miRNAs in ovarian cancer cells and their exosomes compared with normal ovarian surface epithelial cell cells.
P2860
Q26747651-E6C60E30-3E79-465E-B3A4-BE0110B0CD84Q28596243-F19F9EBF-EFF6-46BD-8285-027C373A9CF3Q33725406-438F548B-A038-434F-B836-E17AD263AE7AQ33873642-B58D91BE-81D7-4D8E-A1BB-8D8EEA8D246EQ38739157-4920E409-FDAD-488E-81F9-B4CD15B969D1Q38816040-9076A2E7-826B-439D-87FC-AE0BB2764973Q38834097-9DE779F0-B195-44B5-8150-4422C4614DDDQ38893853-42B3E811-8E7E-44F1-B575-6D63E62256A8Q39454318-455DC571-CC2D-452A-8074-111A23D4CE33Q42359655-597ADECE-B09C-4E30-ABF4-DBAA3B40F2FEQ42511518-601E1ED9-F4A5-4322-8D85-321EEE582F83Q42513953-D10094E4-9D3D-4DB4-86A6-AB65B726FADCQ47436909-0D4EDD41-F1ED-4BF4-8510-B0759E4A06F6Q47715195-159AA56E-5ADE-4828-A39D-02B9741F8225Q50220568-B5BD3547-57D2-4E96-B00E-9F5B318B7F62Q54249872-D0F76032-E6EA-45F9-BF36-EBCD3A63D0DAQ55716532-9AE1534F-1571-4DD5-BFA3-1913A83F85CD
P2860
Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Identification of p62/SQSTM1 a ...... NK signalling in breast cancer
@ast
Identification of p62/SQSTM1 a ...... NK signalling in breast cancer
@en
type
label
Identification of p62/SQSTM1 a ...... NK signalling in breast cancer
@ast
Identification of p62/SQSTM1 a ...... NK signalling in breast cancer
@en
prefLabel
Identification of p62/SQSTM1 a ...... NK signalling in breast cancer
@ast
Identification of p62/SQSTM1 a ...... NK signalling in breast cancer
@en
P2093
P2860
P50
P356
P1476
Identification of p62/SQSTM1 a ...... NK signalling in breast cancer
@en
P2093
Andreas Brech
Anthony Gonçalvès
Ashish Jain
Audrey Restouin
Edwige Belotti
François Bertucci
Ian Macara
Max Chaffanet
Pascal Finetti
Rémy Castellano
P2860
P2888
P356
10.1038/NCOMMS10318
P407
P50
P577
2016-01-12T00:00:00Z
P5875
P6179
1030192260